LUXORA, currently listed as a subsidiary under CBD of Denver Inc, is planning a spin-off for 2024 to operate as an independent company listed on the US stock exchange. This current positioning within CBD of Denver Inc provides a solid foundation for the planned independence. With the spin-off in 2024, LUXORA will reach an important milestone in becoming independently listed on the US stock exchange. This will allow investors direct access to the potentials of the European cannabis market. LUXORA aims to further expand its leadership position in the European cannabis market, with a special focus on innovation, quality, and market penetration.